go-v.orgdoi

Pathophysiologic role of selectins and their ligands in ischemia reperfusion injury

Fady Chamoun, M Burne, M O'Donnell, H Rabb · Frontiers in bioscience · 2000

  • DOI 10.2741/chamoun
  • Publisher Frontiers in Bioscience
  • Type review
  • Issued 2000

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Frontiers in bioscience · Frontiers in Bioscience · review · 2000

Abstract

Research findings are unveiling the potential role of leukocytes and leukocyte adhesion molecules such as selectins in ischemia-reperfusion injury (IRI). "Anti-adhesion" therapy using selectin blocking agents may represent a new approach to treatment of the many diverse clinical disorders in which ischemia-reperfusion occurs, including transplantation, reperfusion after thrombotic events and shock. In this paper we review the pathophysiology of IRI, the different types of selectins and selectin ligands, the clinical implications of selectin blockade in different organs with IRI, and new insights into mechanism of action.

Open the resolved locator · 10.2741/chamoun

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 01:21 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://doi.org/10.2741/chamoun
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.